Search clinical trials for: hypofractionated

Total 327 results

McGill University Health Centre/Research Institute...

Recruiting

Pre-operative RadiothErapy for Soft Tissue SarcOmas (PRESTO)

Soft Tissue Sarcoma Adult

Canada
4D pharma plc

Terminated

A Study of Live Biotherapeutic Product MRx0518 With Hypofractionated Radiation Therapy in Resectable Pancreatic Cancer

Pancreatic Cancer

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
Robert L. Sloan Fund for Cancer Research

Withdrawn

Neoadjuvant Short-course Hypofractionated PBT for Non-metastatic RPS (PROTONS-RPS)

Retroperitoneal Sarcoma

United States
Children's Cancer Hospital Egypt 57357

Completed

Hypofractionated Radiotherapy Versus Conventional Radiotherapy in Diffuse Brainstem Glioma in Children

Pediatric Brain Stem Glioma

Egypt
Maria Sklodowska-Curie National Research Institute...

Unknown

Preoperative Hyperfractionated Radiotherapy or Radiochemotherapy in Locally Advanced Rectal Cancer.

Rectal Cancer

Poland
European Institute of Oncology

Recruiting

Lymphedema Evaluation After Adjuvant Hypofractionated Radiotherapy for 1-2 Macrometastatic Sentinel Lymph Nodes (AXILL-ART)

Breast Cancer | Radiotherapy Side Effect | Arm Lymphedema

Italy
Chang Gung Memorial Hospital

Recruiting

A Neurocognitive Study in Patients With Brain Oligometastases Receiving Hypofractionated SRT (HF-SRT)

Brain Metastases, Adult

Taiwan
West China Hospital
First Affiliated Hospital of Chongqing Medical University; Sichuan Cancer Hospital... and other collaborators

Recruiting

Sintilimab Plus Hypofractionated Radiotherapy for MSI-H/dMMR Rectal Cancer

Rectal Cancer | Radiotherapy | Anti-PD-1 Antibody | MSI-H | Mmr Deficiency

China
University of Kansas Medical Center

Active, not recruiting

Hypofractionated Radiation Therapy for Patients With Breast Cancer Receiving Regional Nodal Irradiation

Breast Cancer

United States
Maria Sklodowska-Curie National Research Institute...

Unknown

Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas (SINDIR)

Sarcoma | Leiomyosarcoma | Fibrosarcoma | Myxoid Liposarcoma | Synovial Sarcoma | Undifferentiated Pleomorphic Sarcoma | Alveolar Soft Part Sarcoma | Liposarcoma, Dedifferentiated | Clear Cell Sarcoma | Malignant Peripheral Nerve Sheath Tumors | Pleomorphic Rhabdomyosarcoma

Poland
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Hypofractionated Radiotherapy for Small Cell Lung Cancer

Small Cell Carcinoma | Lung Neoplasm

Canada
Barretos Cancer Hospital

Withdrawn

Exclusive Hypofractionated Stereotactic Radiotherapy in Non-resectable Single Brain Metastasis

Cancer | Metastasis

Brazil
European Institute of Oncology

Recruiting

CyberKnife Ultra-hypofractionated SBRT for Localized PROStatE cancEr (PRO-SPEED)

Prostate Cancer

Italy
Stanford University
LUNGevity Foundation

Recruiting

Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer

Lung Cancer

United States
Grupo de Investigación Clínica en Oncología Radioterapia

Recruiting

Multicenter Study of Hypofractionated Postoperative Radiotherapy in Patients Diagnosed With Prostate Carcinoma

Prostate Cancer

Spain
Medical University of Vienna

Recruiting

Hypofractionated Stereotactic Linear Accelerator Radiotherapy of Uveal Melanoma

Uveal Melanoma

Austria
Prevent Senior Institute

Completed

Evaluate the Effectiveness and Toxicity of Adjuvant Ultra-hypofractionated Radiotherapy for Breast Cancer

Breast Cancer Female

Brazil
Groupe Oncologie Radiotherapie Tete et Cou
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Non Inferiority Trial of Standard RT Versus Hypofractionated Split Course in Elderly Vulnerable Patients With HNSCC (ELAN-RT)

Head and Neck Squamous Cell Carcinoma

France, Monaco
Tampere University Hospital

Completed

Prostate Cancer Stereotactic Radiotherapy (ESKO)

Prostate Neoplasms | Toxicity Due to Radiotherapy

Finland
University of Texas Southwestern Medical Center
National Cancer Institute (NCI)

Completed

Specialized Radiation Therapy in Treating Patients With Stage II, Stage III, Stage IV, or Recurrent Non-Small Cell Lung Cancer and Poor Performance Status

Lung Cancer

United States
The Clatterbridge Cancer Centre NHS Foundation...

Completed

BIOPROP20: Biologically Optimised IMRT for Prostate Radiotherapy Hypofractionated Radiotherapy With Intra-prostatic Boosts to Tumour Nodules in Men With Intermediate and High Risk Prostate Cancer (BIOPROP20)

Prostate Cancer

United Kingdom
Maria Sklodowska-Curie National Research Institute...

Active, not recruiting

Hypofractionated Radiotherapy in Locally Advanced Myxoid Liposarcomas of Extremities or Trunk Wall (LIPO-MYX Trial) (LIPOMYX)

Myxoid Liposarcoma

Poland
University Medical Center Groningen
Dutch Cancer Society

Recruiting

PSMA-PET Guided Hypofractionated Salvage Prostate Bed Radiotherapy (PERYTON)

Prostate Cancer | Cancer Recurrence

Netherlands
Zhejiang Cancer Hospital
Chinese PLA General Hospital; First Affiliated Hospital, Sun Yat-Sen University and other collaborators

Recruiting

A Prospective Study Comparing Two Radiotherapy Dose/Fraction and Omitting CTVs of the Primary Tumor in Limited SCLC (CTV)

Small Cell Lung Cancer Limited Stage

China
University Of Perugia

Recruiting

Ultra-hypofractionated Radiotherapy in Breast Cancer Patients

Female Breast Cancer

Italy
University of Colorado, Denver

Active, not recruiting

Shorter Course Radiation for the Treatment of Breast Cancer That Has Spread to Lymph Nodes

Breast Cancer

United States
European Institute of Oncology

Active, not recruiting

Short-term High Precision Radiotherapy for Early Prostate Cancer With Concomitant Boost on the Dominant Lesion

Adenocarcinoma of Prostate

Italy
Danish Breast Cancer Cooperative Group
Danish Cancer Society

Active, not recruiting

Hypofractionated Versus Standard Fractionated Whole Breast Irradiation to Node-negative Breast Cancer Patients

Breast Cancer | Carcinoma in Situ of the Breast

Denmark
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Conventional or Hypofractionated Radiation Therapy in Treating Patients With Prostate Cancer

Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8

United States
Centre Jean Perrin
GORTEC

Active, not recruiting

STEREO-POSTOP 01 (PostOperative Hypofractionated Stereotactic Body Radiotherapy ) - GORTEC 2017-03 (STEREOPOSTOP)

Head and Neck Neoplasms

France
Fudan University

Unknown

Hypofractionated PBI After BCS for Low-risk Breast Cancer Patients

Breast Cancer

China
Cairo University

Unknown

A Study Comparing Hypofractionated Dose Escalated VMAT to Conventional CCRT in Locally Advanced Head and Neck Cancer

Locally Advanced Head and Neck Cancer
AC Camargo Cancer Center

Unknown

Single Fraction HDR Brachytherapy Plus Hypofractionated EBRT for Low-risk Prostate Cancer: Phase II Trial (AC-P01)

Prostatic Neoplasms

Brazil
American College of Radiology
RTOG Foundation

Not yet recruiting

Testing the Safety of Giving a Standard Dose of Radiation Over a Shorter Period of Time for Patients Who Had Surgery for Intermediate-Risk Head and Neck Cancer

Head and Neck Cancer | Head and Neck Squamous Cell Carcinoma | Squamous Cell Carcinoma of the Larynx | Squamous Cell Carcinoma of the Oral Cavity | Squamous Cell Carcinoma of the Oropharynx
Dr. Patrick Cheung

Active, not recruiting

Hypofractionated Boost vs Conventionally Fractionated Boost for Localized High Risk Prostate Cancer

Prostate Cancer

Canada
Emory University

Completed

Hypofractionated Radiotherapy in Breast Cancer

Inflammation | Cancer, Breast

United States
University of Rochester

Completed

Study for Using Radiosurgery on Limited Metastases of Breast Cancer

Breast Cancer, Metastatic

United States
Ahmed Ahm

Unknown

Post Mastectomy Hypofractionated Radiotherapy in High Risk Breast Cancer

Breast Cancer

Egypt
Changhai Hospital

Recruiting

Hypofractionated Post-prostatectomy Radiotherapy (HYPORT)for Localized Prostate Cancer

Localized Prostate Cancer

China
Consorci Sanitari de Terrassa

Completed

Hypofractionated Radiotherapy for Prostate Cancer (HRT20)

Prostate Cancer

Spain
Istituto Clinico Humanitas

Terminated

Randomized Study on Postmenopausal Women With Early Stage Breast Cancer: WBI Versus APBI

Cancer of Breast

Italy
IRCCS Azienda Ospedaliero-Universitaria di Bologna

Completed

Modulated Accelerated RAdiotherapy in Early Breast Cancer

Breast Cancer | Radiation Toxicity
Barretos Cancer Hospital

Withdrawn

Phase I Dose Escalation in Patients With 1-3 Unresectable Brain Metastases

Brain Metastases

Brazil
Provision Center for Proton Therapy
Center for Biomedical Research, LLC

Recruiting

Hypofractionated Image Guided Proton Therapy for Low andIntermediate Risk Prostate Cancer

Prostate Cancer

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Terminated

Study of Hypofractionated Radiotherapy Alone in Locally Advanced Nonsmall Cell Lung Cancer Patients

Nonsmall Cell Lung Cancer Stage III | Nonsmall Cell Lung Cancer, Stage II

United States
Tatarstan Cancer Center

Enrolling by invitation

Moderately Hypofractionated Radiotherapy for Prostate Cancer.

Prostatic Neoplasms | Genital Neoplasms

Russian Federation
National University Hospital, Singapore
Tan Tock Seng Hospital

Unknown

Hypofractionated Intensity Modulated Chemoradiotherapy to Treat Locally Advanced Non-Small Cell Lung Cancer

Stage III Non-Small Cell Lung Cancer

Singapore
Fudan University

Recruiting

Hypofractionated Vs Conventional Fractionated Postmastectomy Radiotherapy for High Risk Breast Cancer

Breast Cancer

China
University of Chicago

Recruiting

Study of Pelvic Hypofractionated Radiotherapy in Endometrial Cancer

Endometrial Cancer

United States
Tata Medical Center

Completed

Short Course Radiotherapy for Localized Prostate Cancer (SHORT)

Adenocarcinoma of Prostate

India

Search clinical trials for: hypofractionated

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Italy

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations